U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Key Account Manager Rheumatology - West, South & Central Sweden

Account ManagementUpdated on Nov 14
Full-timeStockholm, SwedenNo salary listed

About the Job

Requirements

  • A bachelor's or master's degree, or equivalent, in life sciences, healthcare, business, or a related field.
  • A required Swedish industry ethical certification.
  • Spoken and written Swedish and English.
  • Experience leading strategic commercial and customer engagement initiatives in the pharmaceutical industry, including ownership of account strategy and execution.
  • Knowledge of Swedish healthcare, regional treatment recommendations, and regional decision-making.
  • A valid driving license.

Responsibilities

  • Create tailored territory, engagement, and account plans for prioritized regions.
  • Foster sustainable performance across healthcare professionals, clinics, and accounts.
  • Personalize engagement across in-person, remote, digital, and project-based channels.
  • Translate customer, patient, and market insights into clear actions.
  • Map therapy-specific regional groups, treatment recommendations, opportunities, and barriers.
  • Lead regional collaboration across functions while ensuring responsible, compliant customer engagement.
  • Build trusted partnerships with clinics, healthcare professionals, and therapy-specific regional groups, including rheumatology Drug Formulary Committees, in line with Swedish legislation, industry ethics, UCB policies, and internal approvals.
  • Partner closely with colleagues in Medical, Marketing, Market Access, and other functions to coordinate regional engagement and share insights.

Desired Qualifications

  • Experience in rheumatology.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs